Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
5.86
-0.05 (-0.93%)
Aug 14, 2025, 1:58 PM - Market open

Tenax Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-31.48-17.6-7.71-11.05-32.47-9.85
Upgrade
Depreciation & Amortization
--0.010.110.110.11
Upgrade
Loss (Gain) From Sale of Assets
--0-0--
Upgrade
Loss (Gain) From Sale of Investments
----0.010.01
Upgrade
Stock-Based Compensation
9.731.130.190.370.770.35
Upgrade
Other Operating Activities
0.010.020.02021.340
Upgrade
Change in Accounts Receivable
-0.60.06-0.31-0.36-0.020.7
Upgrade
Change in Accounts Payable
-0.371.061.65-0.34-0.54-0.54
Upgrade
Change in Other Net Operating Assets
2.870.520.24-0.12-0.04-0.06
Upgrade
Operating Cash Flow
-19.84-14.81-5.9-11.39-10.86-9.27
Upgrade
Capital Expenditures
----0-0.01-0
Upgrade
Sale of Property, Plant & Equipment
--0---
Upgrade
Investment in Securities
----0.460.02
Upgrade
Investing Cash Flow
--0-00.450.02
Upgrade
Long-Term Debt Issued
-----0.24
Upgrade
Total Debt Issued
-----0.24
Upgrade
Short-Term Debt Repaid
--0.5-0.62---
Upgrade
Total Debt Repaid
-0.28-0.5-0.62---
Upgrade
Net Debt Issued (Repaid)
-0.28-0.5-0.62--0.24
Upgrade
Issuance of Common Stock
0.690.07000.5410.35
Upgrade
Other Financing Activities
115.51100.314.197.939.19-
Upgrade
Financing Cash Flow
115.9299.8713.577.939.7410.6
Upgrade
Net Cash Flow
96.0885.067.67-3.46-0.671.34
Upgrade
Free Cash Flow
-19.84-14.81-5.9-11.39-10.86-9.28
Upgrade
Free Cash Flow Per Share
-0.59-0.97-23.76-619.37-844.53-
Upgrade
Levered Free Cash Flow
-19.02-9.41-3.79-7.77-19.33-5.49
Upgrade
Unlevered Free Cash Flow
-19.02-9.39-3.77-7.76-19.33-5.49
Upgrade
Change in Working Capital
1.91.641.58-0.82-0.610.1
Upgrade
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q